Cite

HARVARD Citation

    Jassem, J. et al. (n.d.). 143TiPIMpower110: Phase III trial of 1L atezolizumab in PD-L1–selected chemotherapy-naive NSCLC. Annals of oncology. p. . [Online]. 
  
Back to record